Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Mucosal Immunology
|
December 11, 2024
IL-33 is associated with alveolar dysfunction in patients with viral lower respiratory tract disease
Ian C Scott, Natalie van Zuydam, Jennifer A Cann, et al.
Journal for Immunotherapy of Cancer
|
August 4, 2025
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine release
Miguel Gaspar, Marina Natoli, Laure Castan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 25, 2016
A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding
Julie Douthwaite, Jacques Moisan, Cyril Privezentzev, et al.
Journal of Molecular Biology
|
June 6, 2024
Robust Prediction of Relative Binding Energies for Protein-Protein Complex Mutations Using Free Energy Perturbation Calculations
Jared M Sampson, Daniel A Cannon, Jianxin Duan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 23, 2017
Correction: A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding
Julie Douthwaite, Jacques Moisan, Cyril Privezentzev, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2024
Robust prediction of relative binding energies for protein-protein complex mutations using free energy perturbation calculations
Jared M Sampson, Daniel A Cannon, Jianxin Duan, et al.
Mabs
|
March 4, 2014
A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthma
E Suzanne Cohen, Claire L Dobson, Helena Käck, et al.
Oncoimmunology
|
April 14, 2017
MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential
Natalie J Tigue, Lisa Bamber, John Andrews, et al.
Scientific Reports
|
June 17, 2023
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
Elizabeth England, D Gareth Rees, Ian Christopher Scott, et al.
Annals of the Rheumatic Diseases
|
November 22, 2018
Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses
Bo Chen, Katherine A Vousden, Brian Naiman, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Mucosal Immunology
|
December 11, 2024
IL-33 is associated with alveolar dysfunction in patients with viral lower respiratory tract disease
Ian C Scott, Natalie van Zuydam, Jennifer A Cann, et al.
Journal for Immunotherapy of Cancer
|
August 4, 2025
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine release
Miguel Gaspar, Marina Natoli, Laure Castan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 25, 2016
A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding
Julie Douthwaite, Jacques Moisan, Cyril Privezentzev, et al.
Journal of Molecular Biology
|
June 6, 2024
Robust Prediction of Relative Binding Energies for Protein-Protein Complex Mutations Using Free Energy Perturbation Calculations
Jared M Sampson, Daniel A Cannon, Jianxin Duan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 23, 2017
Correction: A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding
Julie Douthwaite, Jacques Moisan, Cyril Privezentzev, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2024
Robust prediction of relative binding energies for protein-protein complex mutations using free energy perturbation calculations
Jared M Sampson, Daniel A Cannon, Jianxin Duan, et al.
Mabs
|
March 4, 2014
A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthma
E Suzanne Cohen, Claire L Dobson, Helena Käck, et al.
Oncoimmunology
|
April 14, 2017
MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential
Natalie J Tigue, Lisa Bamber, John Andrews, et al.
Scientific Reports
|
June 17, 2023
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
Elizabeth England, D Gareth Rees, Ian Christopher Scott, et al.
Annals of the Rheumatic Diseases
|
November 22, 2018
Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses
Bo Chen, Katherine A Vousden, Brian Naiman, et al.
Page
of 5